Press release
Antithrombin Market is estimated to be US$ 849.87 million by 2030 with a CAGR of 4.3% during the forecast period 2030 With Top Most Key Players - Takeda Pharmaceuticals, Siemens AG, Axis-Shield Plc., Grifols, CSL Limited, Thermo Fisher Scientific, Octapha
The protein which blocks thrombin is called as antithrombin. Antithrombin is the glycoprotein which is synthesized by the liver. Antithrombin inhibits the proteases due to belonging to the family of serpins. Antithrombin used to thin the blood slightly from clotting alot. Antithrombin is an endogenous anticoagulant. Antiplatelets are the drugs used for preventing the formation of blood clots. Aspirin is the common antiplatelet drug. Other antiplatelet drug includes prasugrel, clopidogrel and ticagrelor. The deficiency or low level of antithrombin causes abnormal blood clots which results in the blockage of blood flow and damage the organs. Antithrombin maintains the balance in the coagulation system. The adequate level of antithrombin is important to be present in the body to avoid the high risk of thrombophilias. Antithrombin is used in surgical procedures to prevent the blood clotting. Use of antithrombin concentrates are useful in antithrombin deficiency. Antithrombin has anti-aggregant and anti-inflammatory properties. Antithrombin in the plasma ranges from 80% to 120%. Antithrombin concentrates are prepared from human plasma. Thus, increased use of antithrombin has given rise in the market growth. Global Antithrombin Market size accounted for US$ 577.2 million in 2020 and is estimated to be US$ 849.87 million by 2030 and is anticipated to register a CAGR of 4.3%.To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Antithrombin-Market-4929
The report "Global Antithrombin Market, By Type (Thrombolytic Drugs, Anticoagulant, Antiplatelet and Others), By Application (Therapeutics, Research & Development, Diagnostics, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030"
Key Highlights:
• In 2021, (PubMed Central), adequate Antithrombin III level predicted the survival in severe pandemic of COVID-19 Pneumonia. Antithrombin III has become the most potent endogenous anticoagulant. Antithrombin III is thus required for the clinical efficacy of heparin.
• In 2022, (csl.com), CSL Limited announced the positive top line phase 3 results for Garadacimab which has become preventive treatment in patients with HAE (Hereditary Angioedema). Garadacimab has become the potentially transformative first-in-class therapy for the patients having HAE (Hereditary Angioedema).
Analyst View:
Antithrombin has become important as it prevents excess blood clotting. The use of antithrombin in surgical procedures is increased due to rise in chronic diseases like heart disease, kidney disease. During surgical procedure antithrombin is required to prevent forming of blood clots. Antithrombin deficiency causes risk of thrombophilias. However, increase in surgical procedures and rise in deficiency of antithrombin has driven rise in demand of antithrombin which will be able to boosts the growth of the market. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish position in the market.
Click To Get Sample Report:-
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4929
Segments Covered in the Report:
Global Antithrombin Market, By Type:
• Thrombolytic Drugs
• Anticoagulant
• Antiplatelet
• Others
Global Antithrombin Market, By Application:
• Therapeutics
• Research & Development
• Diagnostics
• Others
Key Market Insights from the report:
Global Antithrombin Market size accounted for US$ 577.2 million in 2020 and is estimated to be US$ 849.87 million by 2030 and is anticipated to register a CAGR of 4.3%. The Global Antithrombin Market is segmented based on Type, Application and Region.
• Based on Type, Global Antithrombin Market is segmented into Thrombolytic Drugs, Anticoagulant, Antiplatelet and others.
• Based on Application, Global Antithrombin Market is segmented into Therapeutics, Research & Development, Diagnostics, and others.
• By Region, the Global Antithrombin Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Competitive Landscape & their strategies of Global Antithrombin Market:
The prominent players operating in the Global Antithrombin Market includes, Takeda Pharmaceuticals, Siemens AG, Axis-Shield Plc., Grifols, CSL Limited, Thermo Fisher Scientific, Octapharma AG, Lee Biosolutions Inc., Shire Plc., LFB USA, Scripps Laboratories Inc., Kedrion S.p.A., Novartis International AG, Bristol-Myers Squibb Company, Merck & Co., and others.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
Other Related Reports:-
https://www.openpr.com/news/2248689/global-nitrous-oxide-market-keyplayers-matheson-tri-gas
https://www.openpr.com/news/2248688/global-construction-chemicals-market-rpm-international-sika
https://www.openpr.com/news/2247943/global-brand-drugs-market-pfizer-inc-roche-inc-sanofi
964 E. BadilloStreet #2042 Covina, CA 91724
US toll free: +1 860 531 2701
Rest of world: + 91 7775049802
Email:sales@prophecymarketinsights.com
Website:www.prophecymarketinsights.com
About Us:Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antithrombin Market is estimated to be US$ 849.87 million by 2030 with a CAGR of 4.3% during the forecast period 2030 With Top Most Key Players - Takeda Pharmaceuticals, Siemens AG, Axis-Shield Plc., Grifols, CSL Limited, Thermo Fisher Scientific, Octapha here
News-ID: 2775502 • Views: …
More Releases from Prophecy Market Insights

Power Purchase Agreement (PPA) Market Poised for Strong Growth Amid Rising Renew …
Author: Shweta R., Business Development Specialist | Prophecy Market Insights
Introduction
The Power Purchase Agreement (PPA) Market is experiencing remarkable momentum, driven by the global transition toward renewable energy, carbon reduction targets, and rising demand for cost-effective electricity procurement models.
PPAs-long-term contracts between electricity producers and buyers-are becoming a critical mechanism for corporations, utilities, and governments to achieve energy security, price stability, and sustainability commitments. With the accelerating deployment of solar, wind, and…

Nutraceutical Packaging Market to Witness Robust Growth Amid Rising Health and W …
Author: Shweta R., Business Development Specialist | Prophecy Market Insights
Introduction
The Nutraceutical Packaging Market is witnessing significant growth, fueled by rising consumer awareness around health, nutrition, and preventive healthcare. Nutraceuticals-ranging from dietary supplements and functional foods to vitamins, minerals, and herbal products-require specialized packaging that ensures shelf life, product integrity, safety, and consumer appeal.
With increasing demand for convenient, eco-friendly, and innovative packaging solutions, companies are investing in advanced materials, smart labeling,…

Japan Regulatory Affairs Outsourcing Market Set to Reach USD 0.4 Billion by 2035 …
Pune, India - September 5, 2025 - The Japan Regulatory Affairs Outsourcing Market is witnessing steady growth as pharmaceutical, biotechnology, and medical device companies increasingly rely on external partners for regulatory compliance. By 2035, the market is projected to reach USD 0.4 billion, rising from USD 0.3 billion in 2025, expanding at a CAGR of 7.71% during the forecast period.
Get a Sample Copy of Report :- https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/5849
This growing demand underscores…

Europe Regulatory Affairs Outsourcing Market to Reach USD 4.2 Billion by 2035, D …
Pune, India - September 2, 2025 - The Europe Regulatory Affairs Outsourcing Market is experiencing steady growth as pharmaceutical, biotechnology, and medical device companies increasingly rely on specialized partners for regulatory compliance. According to recent analysis, the market size was valued at USD 2.0 billion in 2025 and is projected to expand to USD 4.2 billion by 2035, registering a CAGR of 7.70% during the forecast period.
Get Sample Copy of…
More Releases for Antithrombin
Antithrombin Market - From Safety to Success: Antithrombin Solutions for Effecti …
Newark, New Castle, USA: The "Antithrombin Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Antithrombin Market: https://www.growthplusreports.com/report/antithrombin-market/7760
This latest report researches the industry structure, sales, revenue, price and…
Antithrombin Market Size, Share & Growth Report 2030
The global Antithrombin market accounted for USD 543.0 Million in 2020 and is expected to reach USD 820.8 Million by 2028, growing at a CAGR of 5.3% from 2021 to 2028.
Antithrombin is a protein present in the blood stream, which functions as a naturally occurring mild blood thinner. Antithrombin helps to control too much clotting. A person with low antithrombin levels has more tendency to…
Antithrombin Market Report Up to 2031
Visiongain has published a new report on Antithrombin Market Report to 2031. Market is segmented by source (Human, Goat milk, others), By Application (Therapeutics, Research, Diagnostic, Others), By Type (Anticoagulants, Antiplatele, Thrombolytic Drugs). Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report includes detailed Profiles of Leading Antithrombin Companies. PLUS COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/antithrombin-market/#download_sampe_div
The study covers detailed and insightful chapters…
Antithrombin Market Analysis 2026
Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin. Antithrombin is produced by liver and consists of 432 amino acids. There are two major reasons of antithrombin deficiency, which include acquired antithrombin deficiency caused due to other diseases such as nephrotic syndrome, liver failure, severe trauma, and metastatic tumors and inherited antithrombin deficiency caused due to a genetic mutation or abnormality. According to the NCBI…
Antithrombin Market - Size, Share, Outlook, 2026
Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin. Antithrombin is produced by liver and consists of 432 amino acids. There are two major reasons of antithrombin deficiency, which include acquired antithrombin deficiency caused due to other diseases such as nephrotic syndrome, liver failure, severe trauma, and metastatic tumors and inherited antithrombin deficiency caused due to a genetic mutation or abnormality. According to the NCBI…
Antithrombin Market analysis 2026
Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin. Antithrombin is produced by liver and consists of 432 amino acids. There are two major reasons of antithrombin deficiency, which include acquired antithrombin deficiency caused due to other diseases such as nephrotic syndrome, liver failure, severe trauma, and metastatic tumors and inherited antithrombin deficiency caused due to a genetic mutation or abnormality. According to the NCBI…